Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
57.95
+1.70 (3.02%)
At close: Dec 2, 2025, 4:00 PM EST
57.89
-0.06 (-0.10%)
After-hours: Dec 2, 2025, 7:23 PM EST

Arrowhead Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 2016 - 2020
7,8704,7692,4082,8803,4986,509
Upgrade
Market Cap Growth
192.69%98.03%-16.40%-17.67%-46.25%47.77%
Upgrade
Enterprise Value
7,6864,5812,4362,7993,1836,017
Upgrade
Last Close Price
57.9534.4919.3726.8733.0562.43
Upgrade
PS Ratio
9.355.75678.1211.9614.3847.07
Upgrade
PB Ratio
16.879.4712.6010.038.3615.92
Upgrade
P/TBV Ratio
17.1410.3913.6111.039.0516.47
Upgrade
P/FCF Ratio
50.1630.40---44.06
Upgrade
P/OCF Ratio
43.8326.56---37.99
Upgrade
EV/Sales Ratio
9.275.52686.0211.6313.0943.51
Upgrade
EV/EBITDA Ratio
62.8637.47----
Upgrade
EV/EBIT Ratio
78.1646.58----
Upgrade
EV/FCF Ratio
48.9929.20---40.72
Upgrade
Debt / Equity Ratio
1.461.464.461.340.200.06
Upgrade
Debt / EBITDA Ratio
5.295.29----
Upgrade
Debt / FCF Ratio
4.684.68---0.17
Upgrade
Asset Turnover
0.660.660.000.330.350.22
Upgrade
Quick Ratio
4.734.736.573.752.672.58
Upgrade
Current Ratio
4.864.866.743.952.922.63
Upgrade
Return on Equity (ROE)
8.67%8.67%-254.98%-59.33%-42.68%-32.36%
Upgrade
Return on Assets (ROA)
4.87%4.87%-39.43%-17.58%-15.91%-15.11%
Upgrade
Return on Capital (ROIC)
5.39%5.39%-43.84%-21.89%-23.88%-20.31%
Upgrade
Return on Capital Employed (ROCE)
8.30%8.30%-58.00%-31.10%-32.30%-26.40%
Upgrade
Earnings Yield
-0.02%-0.03%-24.90%-7.13%-5.03%-2.16%
Upgrade
FCF Yield
1.99%3.29%-25.10%-11.48%-5.40%2.27%
Upgrade
Buyback Yield / Dilution
-11.67%-11.67%-12.21%-1.26%-1.62%-3.00%
Upgrade
Updated Nov 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q